• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一名转移性膀胱移行细胞癌患者在接受吉西他滨治疗后出现中毒性表皮坏死松解症。

Toxic epidermal necrolysis associated with gemcitabine therapy in a patient with metastatic transitional cell carcinoma of the bladder.

作者信息

Mermershtain W, Cohen A D, Lazarev I, Grunwald M, Ariad S

机构信息

Department of Oncology, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

出版信息

J Chemother. 2003 Oct;15(5):510-1. doi: 10.1179/joc.2003.15.5.510.

DOI:10.1179/joc.2003.15.5.510
PMID:14598945
Abstract

The authors report on a case of treatment-related toxic epidermal necrolysis in an elderly man receiving chemotherapy (gemcitabine) for transitional cell carcinoma of bladder and discuss the implications of the case.

摘要

作者报告了一例老年男性在接受治疗（吉西他滨）治疗膀胱移行细胞癌时发生的与治疗相关的中毒性表皮坏死松解症，并讨论了该病例的意义。

相似文献

1
Toxic epidermal necrolysis associated with gemcitabine therapy in a patient with metastatic transitional cell carcinoma of the bladder.一名转移性膀胱移行细胞癌患者在接受吉西他滨治疗后出现中毒性表皮坏死松解症。
J Chemother. 2003 Oct;15(5):510-1. doi: 10.1179/joc.2003.15.5.510.
2
[Toxicity of intravesical gemcitabine in superficial bladder cancer treatment].[吉西他滨膀胱灌注治疗浅表性膀胱癌的毒性]
Farm Hosp. 2014 May 1;38(3):249-51. doi: 10.7399/fh.2014.38.3.646.
3
Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine.一名同时接受放疗和吉西他滨治疗的患者发生史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症。
Anticancer Drugs. 2003 Sep;14(8):659-62. doi: 10.1097/00001813-200309000-00012.
4
Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.吉西他滨用于不可切除的局部晚期或转移性膀胱癌。
Cochrane Database Syst Rev. 2011 Apr 13(4):CD008976. doi: 10.1002/14651858.CD008976.pub2.
5
Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of the bladder.吉西他滨用于膀胱Ta-T1期移行细胞癌的膀胱内治疗
Urology. 2005 Nov;66(5):1141-2; author reply 1142. doi: 10.1016/j.urology.2005.04.068.
6
Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma.吉西他滨治疗转移性移行细胞癌后发生的肿瘤溶解综合征。
Med Oncol. 2007;24(4):455-7. doi: 10.1007/s12032-007-0014-z.
7
Phase I study of radiochemotherapy with gemcitabine in invasive bladder cancer.吉西他滨放化疗治疗浸润性膀胱癌的Ⅰ期研究。
Radiother Oncol. 2012 Mar;102(3):412-5. doi: 10.1016/j.radonc.2011.07.026. Epub 2011 Sep 2.
8
[Gemcitabine in advanced bladder cancer].[吉西他滨用于晚期膀胱癌]
Urologe A. 2003 Jan;42(1):63-77. doi: 10.1007/s00120-002-0222-2. Epub 2002 Dec 19.
9
Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 3. Photo therapy recall with gemcitabine following ultraviolet B treatment.癌症患者的双重诊断以及与吉西他滨相关的皮肤反应：病例3。紫外线B治疗后吉西他滨引发的光疗回忆反应。
J Clin Oncol. 2005 Oct 1;23(28):7224-5. doi: 10.1200/JCO.2005.09.092.
10
Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer.吉西他滨、顺铂和舒尼替尼治疗转移性尿路上皮癌和肌层浸润性膀胱癌的术前治疗。
Clin Genitourin Cancer. 2013 Jun;11(2):175-81. doi: 10.1016/j.clgc.2012.10.001. Epub 2012 Dec 8.

引用本文的文献

1
Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs-An Overview.抗肿瘤药物迟发型超敏反应的评估——综述
Cancers (Basel). 2023 Feb 14;15(4):1208. doi: 10.3390/cancers15041208.
2
Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies.抗癌药物引起的严重皮肤不良反应：抗癌靶向治疗或免疫治疗相关风险的最新综述。
J Immunol Res. 2018 Jan 17;2018:5376476. doi: 10.1155/2018/5376476. eCollection 2018.
3
Life-threatening dermatologic adverse events in oncology.
肿瘤学中危及生命的皮肤不良反应。
Anticancer Drugs. 2014 Feb;25(2):225-34. doi: 10.1097/CAD.0000000000000032.